Skip to main content

Interactions Between Mesenchymal Stem Cells and Dendritic Cells

  • Chapter
  • First Online:

Part of the book series: Advances in Biochemical Engineering/Biotechnology ((ABE,volume 130))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

Ag:

Antigen

DC:

Dendritic cells

GM-CSF:

Granulocyte macrophage-colony stimulating factor

GvHD:

Graft-versus-Host Disease

HGF:

Hepatocyte growth factor

HO-1:

Haemoxygenase-1

HSCT:

Hematopoietic stem cell transplantation

IDO:

Indoleamine 2,3-dioxygenase

IFN-γ :

Interferon-γ

IL:

Interleukin

LPS:

Lipopolysaccharide

MHC:

Major histocompatibility complex

MLR:

Mixed lymphocyte reactions

MSC:

Mesenchymal stem cells

NK cells:

Natural killer cells

NO:

Nitric oxide

PGE2:

Prostaglandin E2

TGF-β :

Transforming growth factor-β

TNF-α :

Tumor necrosis factor-α

References

  1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune responses. Blood 105:1815–1822

    Article  CAS  Google Scholar 

  2. Aldinucci A, Rizzetto L, Pieri L et al (2010) Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. J Immunol 185:5102–5110

    Article  CAS  Google Scholar 

  3. Ball LM, Bernardo ME, Roelofs H et al (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764–2767

    Article  CAS  Google Scholar 

  4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252

    Article  CAS  Google Scholar 

  5. Banchereau J, Briere F, Caux F et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811

    Article  CAS  Google Scholar 

  6. Bassi EJ, de Almeida DC, Moraes-Vieira PM et al (2012) Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev Rep 8:329–342

    Article  CAS  Google Scholar 

  7. Battiwalla M, Hematti P (2009) Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11:503–515

    Article  Google Scholar 

  8. Beyth S, Borovsky Z, Mevorach D et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214–2219

    Article  CAS  Google Scholar 

  9. Cooper MA, Fehniger TA, Fuchs A et al (2004) NK cell and DC interactions. Trends Immunol 25:47–52

    Article  CAS  Google Scholar 

  10. Jiang X-X, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120–4126

    Article  CAS  Google Scholar 

  11. Krampera M (2011) Mesenchymal stromal cell “licensing”: a multistep process. Leukemia 25:1408–1414

    Article  CAS  Google Scholar 

  12. Krampera M, Cosmi L, Angeli R et al (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386–398

    Article  CAS  Google Scholar 

  13. Le Blanc K, Frassoni F, Ball LM et al (2008) Mesenchymal stem cells for treatment of steroid-resistant severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586

    Article  Google Scholar 

  14. Li Y-P, Paczesny S, Lauret E et al (2008) Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180:1598–1608

    CAS  Google Scholar 

  15. Méndez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829–834

    Article  Google Scholar 

  16. Moretta A (2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2:957–965

    Article  CAS  Google Scholar 

  17. Moretta L, Ferlazzo G, Bottino C et al (2006) Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214:219–228

    Article  CAS  Google Scholar 

  18. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499–3506

    Article  CAS  Google Scholar 

  19. Nauta AJ, Kruisselbrink AB, Lurvink E et al (2006) Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080–2087

    CAS  Google Scholar 

  20. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  Google Scholar 

  21. Ramasamy R, Fazekasova H, Lam EW et al (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71–76

    Article  Google Scholar 

  22. Spaggiari GM, Abdelrazik H, Becchetti F et al (2009) Mesenchymal stem cells inhibit dendritic cell maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576–6583

    Article  CAS  Google Scholar 

  23. Tolar J, Le Blanc K, Keating A et al (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28:1446–1455

    Article  Google Scholar 

  24. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736

    Article  CAS  Google Scholar 

  25. van den Berk LC, Roelofs H, Huijs T et al (2009) Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells. Immunology 128:564–572

    Article  Google Scholar 

  26. Zhao Z-G, Xu W, Sun L et al (2012) Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest 41:183–198

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Grazia Maria Spaggiari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 2013

About this chapter

Cite this chapter

Spaggiari, G.M., Moretta, L. (2012). Interactions Between Mesenchymal Stem Cells and Dendritic Cells. In: Weyand, B., Dominici, M., Hass, R., Jacobs, R., Kasper, C. (eds) Mesenchymal Stem Cells - Basics and Clinical Application II. Advances in Biochemical Engineering/Biotechnology, vol 130. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2012_154

Download citation

Publish with us

Policies and ethics